TheraRadar
Data updated: Jun 17, 2026

CORDRAN (flurandrenolide)

Corticosteroid Hormone Receptor Agonists
Dermatology Approved 1963-03-19

CORDRAN is indicated for the treatment of Dermatitis.

Source: FDA Label • ALMIRALL
3
Indications
--
Phase 3 Trials
63
Years on Market

Details

Status
Prescription
First Approved
1963-03-19
Routes
TOPICAL
Dosage Forms
TAPE, OINTMENT, LOTION

Companies

Active Ingredient: FLURANDRENOLIDE

CORDRAN Approval History

1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
66 FDA actions from 1963 to 2017
Jan 2017 SUPPL
Mfg · Manufacturing (CMC)
Jul 2013 SUPPL
Mfg · Manufacturing (CMC)
Jun 2013 SUPPL
Mfg · Manufacturing (CMC)

What CORDRAN Treats

1 indications

CORDRAN is approved for 1 conditions since its original approval in 1963. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Dermatitis
Source: FDA Label

CORDRAN Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

What's emerging in CORDRAN's indications

See all emerging drugs →

Phase 3 candidates targeting molecules with no FDA-approved drug, in indications CORDRAN treats. First-in-class if their pivotal trials read out positive.

Drugs Similar to CORDRAN

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

HYDROCORTISONE VALERATE
HYDROCORTISONE VALERATE
1 shared
GLENMARK PHARMS LTD
Shared indications:
Dermatitis

ALMIRALL's other novel FDA approvals

Other CDER-designated drugs from the same sponsor (2016–2025).

🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

CORDRAN FDA Label Details

Indications & Usage

FDA Label (PDF)

CORDRAN is indicated for the treatment of Dermatitis.

Track CORDRAN with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.